NCT01859988: Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- State
- Completed
- Phase
- Phase 2
- People
- 380 taking part
- Started
- May 2013
- Primary completion
- May 2014
- Arms
- Dupilumab 300 mg qw
- Results
- Posted on the registry
- Papers
- doi:10.1001/jamadermatol.2022.6192, doi:10.1016/j.jaad.2015.10.043, doi:10.1016/j.jaad.2016.04.054, doi:10.1016/s0140-6736(15)00388-8, doi:10.1097/der.0000000000000698, doi:10.1111/cts.13363
- 22 May 2013: Trial registered
- 28 Aug 2017: Trial results posted